Vericel Corp (VCEL)

• Market cap: $1.82B
• 1 day: 5.86%
• 5 days: 0.08%
• 1 month: -2.94%
• 3 months: -9.74%
• 6 months: -5.19%
• Year to date: 0.98%
• 1 year: -36.7%
• 5 years: -29.72%
• 10 years: 1,637.2%
• Sector: Healthcare
• Industry: Biotechnology

About: Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 357